✦ LIBER ✦

CN3 ASSESSING THE MAJOR DRIVERS FOR THE INCREASED HEALTH CARE COSTS ASSOCIATED WITH COLORECTAL CANCER

✍ Scribed by M Rahman; R Weinstein; M Wilcox; A Matcho; S Wong

Book ID: 118610673
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 87 KB
Volume: 12
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)73075-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN55 ASSESSING THE MAJOR DRIVERS FOR TH

PCN55 ASSESSING THE MAJOR DRIVERS FOR THE INCREASED HEALTH CARE COSTS ASSOCIATED WITH BREAST CANCER

✍ M Rahman; R Weinstein; M Wilcox; A Matcho; S Price 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

PCN57 ASSESSING THE MAJOR DRIVERS FOR TH

PCN57 ASSESSING THE MAJOR DRIVERS FOR THE INCREASED HEALTH CARE COSTS ASSOCIATED WITH PROSTATE CANCER

✍ M Rahman; R Weinstein; M Wilcox; A Matcho; B Raghavan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

PIH13 ASSESSING THE INCREASED MATERNAL A

PIH13 ASSESSING THE INCREASED MATERNAL AND NEONATAL HEALTH CARE COSTS ASSOCIATED WITH PREECLAMPSIA

✍ A Chawla; LA White; D Mitchell; E Chang; B Gorin; D Woelkers; J Vargo; M Rahman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Time Costs Associated with Informal Care

Time Costs Associated with Informal Care for Colorectal Cancer: An Investigation of the Impact of Alternative Valuation Methods

✍ Hanly, Paul; CÃ©illeachair, Alan Ã.; Skally, Mairead; OâLeary, Eamonn; Staine 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 370 KB

PCN27 COST MINIMIZATION ANALYSIS OF TEGA

PCN27 COST MINIMIZATION ANALYSIS OF TEGAFUR-URACIL ASSOCIATED TO LEUCOVORIN (UFT/LV) VERSUS CAPECITABINE ALONE FOR METASTATIC COLORECTAL CANCER UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE

✍ Teich, VD; Passos, RBF; Teich, N 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

PCN95 Pharmacoeconomic Analysis of Direc

PCN95 Pharmacoeconomic Analysis of Direct Medical Costs Associated With the Treatment of Advanced Esophago-Gastric Cancer Therapy With Xeloda or 5-Fluorouracil (5-FU) Regimens: Implications for Health Care Utilisation in Australia

✍ G. Tran; S. Hack; A. Kerr; L. Stokes; P. Gibbs; T. Price; C. Todd 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB